Medical Properties Trust stock gains 7.94 percent on refinancing

Published on 09/22/2026 at 13:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medical Properties Trust stock closed at USD 3.67 on September 21, 2026, up 7.94 percent. The latest quarter delivered EPS of USD 0.15.

MPW, US58463J3041, Illustration mit AI erstellt.

Medical Properties Trust stock (ISIN US58463J3041) closed at USD 3.67 on the NYSE on September 21, 2026, gaining 7.94 percent from the prior close. The move followed a refinancing announcement covering USD 2.4 billion of private transactions, according to the company announcement published through OTC Markets on September 21, 2026.

Refinancing targets debt maturities

The announced transaction is designed to extend debt maturities to 2032, giving the healthcare real estate investment trust a longer repayment schedule. The financing figure of USD 2.4 billion is the central balance-sheet measure behind the latest share-price reaction.

MarketBeat lists Medical Properties Trust at a market capitalization of USD 2.19 billion and shows volume of 14.17 million shares as of September 21, 2026. That volume was above the listed average of 9.86 million shares, while the stock remained within a 52-week range of USD 3.36 to USD 6.47.

Quarterly earnings met estimates

Medical Properties Trust reported earnings of USD 0.15 per share for the quarter reported on August 10, 2026, matching the consensus estimate of USD 0.15, according to MarketBeat. Revenue increased 7.9 percent from the same quarter a year earlier, providing a quantified operating comparison alongside the refinancing news.

The latest balance-sheet context remains important because MarketBeat reports long-term debt of USD 9.7 billion in the first quarter of 2026, up 2.1 percent from the same quarter a year earlier. The refinancing therefore addresses maturity timing, while the total debt load remains a key counter-factor for the stock.

Stock remains below yearly high

At USD 3.67 on September 21, 2026, the shares stood USD 2.80 below the 52-week high of USD 6.47 and USD 0.31 above the 52-week low of USD 3.36. The valuation data show a market capitalization of USD 2.19 billion and a price-to-book ratio of 0.48 as of the same market-data snapshot.

MarketBeat records a consensus rating of Sell and an average price target of USD 4.15 as of September 22, 2026. The target is USD 0.48 above the September 21 closing price, but the rating and the reported debt figures keep the refinancing benefit closely tied to execution.